Our Goal
Saptalis’ goal is to create value through innovative R&D, aggressively build a product development pipeline and secure FDA marketing approval for multiple ANDA (Abbreviated New Drug Application) submissions. We will also enhance value by investing in our own manufacturing capabilities to support product-life cycle: from clinical batch production to commercial supply.
Located in the Hauppauge Industrial Park on Long Island, NY, Saptalis Pharmaceuticals has a fully equipped Research & Development facility designed and operated to meet cGMP requirements.